Bio Green Med Solution, Inc.
BGMS
$1.67
-$0.02-1.18%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 81.00K | 10.00K | 14.00K | 43.00K | 74.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 81.00K | 10.00K | 14.00K | 43.00K | 74.00K |
| Cost of Revenue | 64.00K | -- | -- | -- | -- |
| Gross Profit | 17.00K | 10.00K | 14.00K | 43.00K | 74.00K |
| SG&A Expenses | 7.42M | 7.65M | 8.03M | 5.41M | 6.34M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 9.25M | 10.37M | 12.70M | 12.05M | 15.61M |
| Operating Income | -9.17M | -10.36M | -12.69M | -12.00M | -15.54M |
| Income Before Tax | -4.24M | -5.42M | -7.78M | -11.99M | -15.83M |
| Income Tax Expenses | 1.20M | 986.00K | 572.00K | -782.00K | -2.40M |
| Earnings from Continuing Operations | -5.44 | -6.41 | -8.35 | -11.21 | -13.43 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -5.44M | -6.41M | -8.35M | -11.21M | -13.43M |
| EBIT | -9.17M | -10.36M | -12.69M | -12.00M | -15.54M |
| EBITDA | -9.17M | -10.35M | -12.68M | -12.00M | -15.52M |
| EPS Basic | -82.18 | -124.67 | -295.33 | -295.23 | -215.98 |
| Normalized Basic EPS | -35.05 | -65.04 | -64.10 | -60.47 | -30.31 |
| EPS Diluted | -82.18 | -124.67 | -295.33 | -295.23 | -215.98 |
| Normalized Diluted EPS | -35.05 | -65.04 | -64.10 | -60.47 | -30.31 |
| Average Basic Shares Outstanding | 3.69M | 1.82M | 947.10K | 83.20K | 44.70K |
| Average Diluted Shares Outstanding | 3.69M | 1.82M | 966.00K | 102.10K | 63.60K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -0.75% | -0.64% | -- | -- | -0.37% |